Vanguard Group Inc. Has $13.21 Billion Stake in Gilead Sciences, Inc. $GILD

Vanguard Group Inc. holds a significant stake of 118,983,644 shares, valued at $13.21 billion, in Gilead Sciences, despite a slight reduction of 0.3% in Q3. Gilead recently reported better-than-expected Q4 results, raising its FY2026 guidance and leading to multiple analyst price target increases, with a consensus of “Moderate Buy” at $152.50. The company also increased its quarterly dividend to $0.82, reflecting positive sentiment and strong financial performance.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin

Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate App
Community
English
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)